Back to Companies
Silexion Therapeutics Corp
SLXNNasdaqCIK: 0002022416
Over the 12 most recent insider filings, Silexion Therapeutics Corp (SLXN) has seen activity from 9 distinct insiders — no open-market buying or selling. Levin Ilan (Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $1.8M by Levin Ilan. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$1.8M
Purchases
$0
Sales
$0
Unique Insiders
9
Recent Insider Trades
12 loaded
| Jun 8 | SLXN Silexion Therapeutics Corp | Shirvan Mitchell | CSO and CDO | Grant | $0 |
| Jun 8 | SLXN Silexion Therapeutics Corp | Hadar Ilan | Chairman and CEO, Director | Grant | $0 |
| Jun 8 | SLXN Silexion Therapeutics Corp | Horenshtein Hadar Mirit | CFO and Secretary | Grant | $0 |
| Feb 25 | SLXN Silexion Therapeutics Corp | Noy Shlomo | Director | Grant | $17.6K |
| Feb 23 | SLXN Silexion Therapeutics Corp | Horenshtein Hadar Mirit | CFO and Secretary | Grant | $0 |
| Feb 23 | SLXN Silexion Therapeutics Corp | Peled Amnon | Director | Grant | $14.7K |
| Jan 27 | SLXN Silexion Therapeutics Corp | Levin Ilan | Director, 10% Owner | Grant | $1.8M |
| Dec 31 | SLXN Silexion Therapeutics Corp | Alon Ruth | Director | Grant | $0 |
| Dec 31 | SLXN Silexion Therapeutics Corp | Peled Amnon | Director | Grant | $0 |
| Dec 31 | SLXN Silexion Therapeutics Corp | Lushi Avner | Director | Grant | $0 |
| Dec 31 | SLXN Silexion Therapeutics Corp | Noy Shlomo | Director | Grant | $0 |
| Dec 31 | SLXN Silexion Therapeutics Corp | Abramov Dror Yosef | Director | Grant | $0 |
12 filings